Brief: IN8bio Reports Fourth Quarter And Full-Year 2022 Financial Results And Provides Corporate Update
30/03/2023 21:54
March 30 (Reuters) - IN8BIO, Inc. INAB.O :
* IN8BIO REPORTS FOURTH QUARTER AND FULL-YEAR 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* IN8BIO, INC.-NET LOSS OF $7.8 MILLION, OR $0.32 PER BASIC
AND
DILUTED COMMON SHARE, FOR THREE MONTHS ENDED DECEMBER 31, 2022
Source text for Eikon: ID:nGNX6T4hPf
Further company coverage: INAB.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on IN8bio
See all newsIN8bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm IN8bio's Q2 net loss narrows as expenses decline
IN8bio Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering
IN8bio Q1 net loss narrows as R&D expenses fall